Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Syros Pharmaceuticals, Inc. (SYRS)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/13/2022 |
3
| Quirk Gerald E (Chief Legal Officer) has filed a Form 3 on Syros Pharmaceuticals, Inc. |
| 09/19/2022 |
3
| TYSON TIMOTHY (Director) has filed a Form 3 on Syros Pharmaceuticals, Inc. |
| 09/19/2022 |
3
| OH ANDREW M. (Director) has filed a Form 3 on Syros Pharmaceuticals, Inc. |
| 10/13/2021 |
3
| Haas Jason (CFO) has filed a Form 3 on Syros Pharmaceuticals, Inc. |
| 09/28/2021 |
3
| Chee Conley (Chief Commercial Officer) has filed a Form 3 on Syros Pharmaceuticals, Inc. |
| 09/10/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/10/2021 |
3
| Stephens Kristin (Chief Development Officer) has filed a Form 3 on Syros Pharmaceuticals, Inc. |
| 09/09/2020 |
3
| Eckhardt Sue Gail (Director) has filed a Form 3 on Syros Pharmaceuticals, Inc. |
| 12/20/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/12/2019 |
3
| Shaw Alice Tsang (Director) has filed a Form 3 on Syros Pharmaceuticals, Inc. |
| 06/15/2018 |
3
| BONNEY MICHAEL W (Director) has filed a Form 3 on Syros Pharmaceuticals, Inc. |
| 03/12/2018 |
3
| Ferra Joseph J Jr (CFO) has filed a Form 3 on Syros Pharmaceuticals, Inc. |
| 11/14/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 10/06/2017 |
3
| DeSimone Colleen Elizabeth (Principal Accounting Officer) has filed a Form 3 on Syros Pharmaceuticals, Inc. |
| 06/12/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 01/30/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 06/29/2016 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 06/29/2016 |
3
| AISLING CAPITAL III LP (10% Owner) has filed a Form 3 on Syros Pharmaceuticals, Inc. |
| 06/29/2016 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 06/29/2016 |
3
| Polaris Management Co. VII, L.L.C. (10% Owner) has filed a Form 3 on Syros Pharmaceuticals, Inc. |
| 06/29/2016 |
3
| Nashat Amir (10% Owner) has filed a Form 3 on Syros Pharmaceuticals, Inc. |
| 06/29/2016 |
3
| Redmile Group, LLC (10% Owner) has filed a Form 3 on Syros Pharmaceuticals, Inc. |
| 06/29/2016 |
3
| WuXi Healthcare Ventures II, L.P. (10% Owner) has filed a Form 3 on Syros Pharmaceuticals, Inc. |
| 06/29/2016 |
3
| JEB Syros Trust (10% Owner) has filed a Form 3 on Syros Pharmaceuticals, Inc. |
| 06/29/2016 |
3
| Perspecta Trust LLC (10% Owner) has filed a Form 3 on Syros Pharmaceuticals, Inc. |
| 06/29/2016 |
3
| WuXi PharmTech Healthcare Fund I L.P. (10% Owner) has filed a Form 3 on Syros Pharmaceuticals, Inc. |
| 06/29/2016 |
3
| Arch Venture Fund VII LP (10% Owner) has filed a Form 3 on Syros Pharmaceuticals, Inc. |
| 06/29/2016 |
3
| NELSEN ROBERT (10% Owner) has filed a Form 3 on Syros Pharmaceuticals, Inc. |
| 06/29/2016 |
3
| Patel Sanj K (Director) has filed a Form 3 on Syros Pharmaceuticals, Inc. |
| 06/29/2016 |
3
| Olson Eric R (Chief Scientific Officer) has filed a Form 3 on Syros Pharmaceuticals, Inc. |
| 06/29/2016 |
3
| Roth David (Chief Medical Officer) has filed a Form 3 on Syros Pharmaceuticals, Inc. |
| 06/29/2016 |
3
| SHARP PHILIP A (10% Owner) has filed a Form 3 on Syros Pharmaceuticals, Inc. |
| 06/29/2016 |
3
| Conde Jorge (Chief Strategy Officer) has filed a Form 3 on Syros Pharmaceuticals, Inc. |
| 06/29/2016 |
3
| Bancel Stephane (Director) has filed a Form 3 on Syros Pharmaceuticals, Inc. |
|
|
|